Hainan Honz Pharmaceutical Co (300086) — Tangible Net Worth Ratio
Hainan Honz Pharmaceutical Co (300086) has a Tangible Net Worth Ratio of 89.8% as of June 2026. This metric is calculated by deducting intangible assets (CN¥90.88 Million) from net assets (CN¥887.65 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Also explore Hainan Honz Pharmaceutical Co net asset momentum to track the company's year-over-year net asset growth rate.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Hainan Honz Pharmaceutical Co Tangible Net Worth Ratio (2007–2025)
This chart shows how Hainan Honz Pharmaceutical Co's Tangible Net Worth Ratio has changed across 19 annual periods from 2007 to 2025. As of June 2026, the ratio stands at 89.8%, reflecting net assets of CN¥887.65 Million with intangible assets of CN¥90.88 Million CNY. For live market cap and overall valuation, see Hainan Honz Pharmaceutical Co market cap and net worth.
Annual Tangible Net Worth Ratio for Hainan Honz Pharmaceutical Co (2007–2025)
The table below presents the year-by-year Tangible Net Worth Ratio for Hainan Honz Pharmaceutical Co from 2007 to 2025, covering 19 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. Explore Hainan Honz Pharmaceutical Co (300086) reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
| Year | Tangible NW Ratio | Net Assets (CNY) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 89.7% | CN¥921.22 Million | CN¥94.79 Million | CN¥1.79 Billion | ▲ +6.1 pp |
| 2024 | 83.6% | CN¥1.17 Billion | CN¥190.82 Million | CN¥1.98 Billion | ▼ -1.6 pp |
| 2023 | 85.2% | CN¥1.38 Billion | CN¥203.97 Million | CN¥2.17 Billion | ▲ +0.3 pp |
| 2022 | 84.9% | CN¥1.36 Billion | CN¥204.90 Million | CN¥2.29 Billion | ▲ +0.4 pp |
| 2021 | 84.5% | CN¥1.55 Billion | CN¥240.52 Million | CN¥2.46 Billion | ▼ -3.3 pp |
| 2020 | 87.8% | CN¥1.60 Billion | CN¥195.49 Million | CN¥2.61 Billion | ▲ +0.6 pp |
| 2019 | 87.2% | CN¥1.60 Billion | CN¥205.05 Million | CN¥2.19 Billion | ▲ +4.8 pp |
| 2018 | 82.4% | CN¥1.65 Billion | CN¥290.69 Million | CN¥2.18 Billion | ▼ -2.9 pp |
| 2017 | 85.3% | CN¥1.92 Billion | CN¥281.80 Million | CN¥2.24 Billion | ▲ +1.0 pp |
| 2016 | 84.4% | CN¥1.87 Billion | CN¥292.67 Million | CN¥2.19 Billion | ▼ -0.3 pp |
| 2015 | 84.7% | CN¥1.84 Billion | CN¥282.26 Million | CN¥2.09 Billion | ▼ -1.6 pp |
| 2014 | 86.3% | CN¥1.80 Billion | CN¥248.09 Million | CN¥1.93 Billion | ▼ -0.3 pp |
| 2013 | 86.5% | CN¥1.81 Billion | CN¥243.69 Million | CN¥1.90 Billion | ▼ -3.4 pp |
| 2012 | 90.0% | CN¥1.87 Billion | CN¥188.07 Million | CN¥1.97 Billion | ▲ +0.8 pp |
| 2011 | 89.1% | CN¥1.85 Billion | CN¥201.32 Million | CN¥1.96 Billion | ▼ -9.5 pp |
| 2010 | 98.6% | CN¥1.83 Billion | CN¥25.03 Million | CN¥1.90 Billion | ▲ +9.4 pp |
| 2009 | 89.3% | CN¥240.49 Million | CN¥25.83 Million | CN¥294.09 Million | ▲ +8.7 pp |
| 2008 | 80.6% | CN¥150.41 Million | CN¥29.23 Million | CN¥206.34 Million | ▼ -9.5 pp |
| 2007 | 90.0% | CN¥115.89 Million | CN¥11.56 Million | CN¥141.57 Million | — |